XM does not provide services to residents of the United States of America.

Tractor Supply misses quarterly sales estimates on sluggish discretionary demand



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Tractor Supply misses quarterly sales estimates on sluggish discretionary demand</title></head><body>

Oct 24 (Reuters) -Farming supplies retailer Tractor Supply TSCO.O missed third-quarter sales estimates on Thursday, as cost-conscious consumers cut back spending on higher-margin products like generators and hardware.

The company's discretionary items ranging from truck tools to lawn mowers saw sluggish demand, as lower-income customers relentlessly looked for cheaper alternatives for their essential purchases.

Tractor Supply posted third-quarter net sales of $3.47 billion, compared with analysts' average estimates of $3.49 billion, as per data compiled by LSEG.

Analysts from Truist Securities, earlier this month, had raised concerns over the impact of warmer than average weather conditions in July and August pressuring Tractor Supply's quarterly sales.

The company's net income for the quarter ended Sept. 28, decreased 5.3% to $241.5 million from a year ago owing to higher expense from planned growth investments like onboarding of a new distribution center.

Shares of the company were down about 1% in premarket trading.

However, it benefited from lower transportation costs, effective cost management and continued execution of its everyday low price strategy, which involves offering its products at consistently affordable rates throughout the year.

The company's quarterly gross margin expanded 56 basis points to 37.2%.

Tractor Supply expects annual sales to be between $14.85 billion and $15.0 billion, compared with prior forecast of $14.8 billion to $15.0 billion.

It expects annual earnings per share to be in the range of $10.10 to $10.40, compared with previous forecast of $10.00 to $10.40 per share.

Tractor Supply also separately said it would acquire Allivet, a privately held online pet and animal pharmacy, in an all-cash deal.



Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Shailesh Kuber

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.